Resources Contact Us Home
Ultra-high yield intravenous immune globulin preparation

Image Number 3 for United States Patent #7879331.

An efficacious large-scale alcohol-free plasma fractionation production process which produces a high-yielding, non-denatured, double viral-inactivated intravenous human immune gamma globulin (IgG) product. The process employs sodium citrate in two initial fractionation steps, followed by diafiltration to remove sodium citrate.

  Recently Added Patents
Barrier layers comprising Ni-inclusive ternary alloys, coated articles including barrier layers, and methods of making the same
User interfaces
Instrumenting configuration and system settings
Use of natriuretic peptide for treating heart failure
Electronic time stamping apparatus for use with an inground transmitter
Fabrication method of semiconductor device and fabrication method of dynamic threshold transistor
Prodrugs of [4 [4-(5-Aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1H-pyrrolo-pyridin-yl- )-methanones and synthesis thereof
  Randomly Featured Patents
Ink set, ink system and method for printing an image
Hybrid electric vehicle
Methods and apparatus to dynamically control access from virtual private networks to network-based shared resources
Tire tread
Adjustable four-weight shaker head
Device and method for repairing a memory array by storing each bit in multiple memory cells in the array
Reversibly expandable doubly-curved truss structure
Business flow processing method and apparatus
Golf ball with varying land surfaces
Stackable step